CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention
In this webinar, Dr. Egelston discusses recent efforts to isolate and characterize phenotypically and functionally exhausted CD8+ TILs from a subset of breast tumors.
Publish Date:
August 30, 2019
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation
Publish Date: April 20, 2016
